Agencies
Services
Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 19, 2014
| Drug Name | Review Type | Class | Manufacturer |
|---|---|---|---|
| Sovaldi | New Drug Initial Review | Hepatitis C | Gilead |
| Otrexup | New Drug Initial Review | DMARD | Antares |
| Brintellix | New Drug Initial Review | Antidepressant | Takeda |
| Olysio | New Drug Initial Review | Hepatitis C | Johnson & Johnson |
| Natroba | New Drug Appeal | Head Lice | ParaPro |
| Quillivant XR | New Drug Appeal | Stimulant/ADHD | Pfizer |
| Linzess | New Drug Appeal | Guanylate Cyclase-C Agonist | Forest |
| TOBI Podhaler | New Drug Appeal | Aminoglycoside | Novartis |
| Abilify Maintena | PDL Appeal | Atypical Antipsychotic | Otsuka |
| Onglyza | PDL Appeal | DPP-4 Inhibitor | AstraZeneca |